We are live on ! Find out more
HEC

Hudson Executive Capital Portfolio holdings

AUM $151M
1-Year Est. Return 60.14%
This Fund
S&P 500
This Quarter Est. Return
-7.2%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$199M
AUM Growth
-$18.8M
Cap. Flow
+$1.94M
Cap. Flow %
0.97%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
2
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
ACOR
Acorda Therapeutics
ACOR
+$2.64M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$1.23M

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$1.94M

Sector Composition

Rank Sector Weight
1 Healthcare 73.58%
2 Financials 26.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$57.9M 29.13%
971,000
+20,400
+2% +$1.23M
CIT
2
DELISTED
CIT Group Inc.
CIT
$52.5M 26.42%
1,070,857
– –
ATRC icon
3
AtriCure
ATRC
$1.7B
$41.5M 20.87%
1,855,000
– –
ACOR
4
DELISTED
Acorda Therapeutics
ACOR
$21.1M 10.63%
7,446
+1,004
+16% +$2.64M
CVRS
5
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$17.2M 8.67%
11,336,154
– –
MGLN
6
DELISTED
Magellan Health Services, Inc.
MGLN
$8.52M 4.28%
98,700
– –
VIVO
7
DELISTED
Meridian Bioscience Inc
VIVO
– –
-123,300
Closed -$1.94M

Similar funds

SHF
Stage Harbor Financial Westwood, Massachusetts $151M AUM 15.9% 1-Year Est. Return
FWM
Fingerlakes Wealth Management Ithaca, New York $151M AUM 20.78% 1-Year Est. Return
CCM
Crew Capital Management Cincinnati, Ohio $151M AUM 20.49% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BDS
Banco de Sabadell Miami, Florida $151M AUM 22.94% 1-Year Est. Return
MWA
Merkkuri Wealth Advisors Hicksville, New York $151M AUM 14.38% 1-Year Est. Return
WBCM
Wilson & Boucher Capital Management Moraga, California $151M AUM 18.75% 1-Year Est. Return
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return

Hudson Executive Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Hudson Executive Capital held 7 positions worth $199M, down 8.6% from $218M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Hudson Executive Capital's Q3 2017 filing shows 2 increased and 1 closed positions. The largest sale was Meridian Bioscience Inc, an estimated $1.94M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 76% a quarter earlier, followed by Financials.

  • Hudson Executive Capital added most to Acorda Therapeutics in Q3 2017, an estimated $2.64M increase.
  • Hudson Executive Capital fully exited Meridian Bioscience Inc in Q3 2017, selling an estimated $1.94M.
  • Hudson Executive Capital's ten largest holdings make up 100% of its $199M portfolio in Q3 2017.
  • Hudson Executive Capital opened 0 new positions and closed 1 in Q3 2017.
  • Hudson Executive Capital's portfolio value fell 8.6% quarter-over-quarter to $199M.

Based on Hudson Executive Capital's 13F filing for Q3 2017, filed 14 Nov 2017.